Effects of Microtox on Facial Skin Quality, Fine Wrinkles, and Texture

Launched by KALPNA KAY DURAIRAJ, MD, FACS · Sep 17, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at how effective a treatment called microtox is for improving the quality of facial skin, reducing fine wrinkles, and enhancing skin texture. In this study, women between the ages of 18 and 65 who have mild to moderate facial wrinkles and are willing to participate can take part. Participants will be randomly assigned to one of two groups: one group will receive microtox on one side of their forehead and a placebo (saltwater solution) on the other side, while the other group will receive microtox on one side and a different version of the treatment on the other side for comparison.

Participants will have one treatment session and will visit the clinic for assessments at two follow-up appointments, where their progress will be documented with photographs. It’s important to note that women who are pregnant, breastfeeding, or have certain medical conditions or recent cosmetic treatments might not be eligible. Overall, this study aims to find out if microtox can truly help improve the appearance of skin as we age.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Biological females, 18-65 years old, of any race and ethnic background
• • Individuals with mild to moderate facial wrinkles
• • All skin types (Fitzpatrick I-VI)
• • Willingness to participate and provide written informed consent
• • Ability to follow study instructions and likely to complete all required visits
• Exclusion Criteria:
• • Females who are pregnant, breastfeeding, chronically using nonsteroidal anti-inflammatory drugs, have autoimmune conditions or have a known allergy to the study medications.
• • Previous cosmetic procedures near the forehead within the last 6 months or botulinum toxin treatments within the last 4 months
• • Known neuromuscular disorders or a hypersensitivity to botulinum toxin
• • Significant dermatological conditions affecting the face
• • Use of medications affecting neuromuscular function or skin healing within 2 weeks prior to the beginning of study
• • Subject has a condition or is in a situation which, in the opinion of the Investigator, may put the subject at significant risk, may confound the study results, or may interfere significantly with participation in the study.